WASHINGTON, D.C. -- In response to FreedomWorks Foundation’s Regulatory Action Center driving roughly 1,000 comments to OMB supporting greater regulatory transparency, Dan Savickas, FreedomWorks Foundation Regulatory Policy Manager, commented:

WASHINGTON, D.C. -- In response to the Trump Administration’s announcements of CMS loosening regulations for telehealth in Medicare and FDA empowering states on testing in efforts to counter the COVID-19 pandemic, Adam Brandon, FreedomWorks’ President, commented: